Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide
- Status
- COMPLETED
- Phase
- PHASE1
Ph II Study of Azacitidine in Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Azacytidine and Valproic Acid in Patients With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
AVIDA The Vidaza® (Azacitidine) Patient Registry
- Status
- COMPLETED
- Phase
- N/A
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Phase II Study of Maintenance With Azacitidine in MDS Patients
- Status
- TERMINATED
- Phase
- PHASE2
Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE1
Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Azacitidine and Interferon Alfa in Treating Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine in Treating Patients With Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE2
Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2